Guidelines

16 Oct 2023

Updated: WHO Guidelines for malaria

The latest version of the WHO Guidelines for malaria was updated in October 2023. These Guidelines supersede 2 previous WHO publications: the Guidelines for the treatment of malaria, third edition and the Guidelines for malaria vector control.

Dissemination products

03 Jul 2023

WHO guideline on policies to protect children from the harmful impact of food marketing

This WHO guideline provides Member States with recommendations and implementation considerations on policies to protect children from the harmful impact of food marketing, based on evidence specific to children and to the context of food marketing.

Dissemination products

14 Mar 2023

WHO Guidelines for malaria

The WHO Guidelines for Malaria bring together the WHO's most up-to-date recommendations for malaria. These guidelines supersede two previous WHO publications: the 'Guidelines for the treatment of malaria, third edition' and the 'Guidelines for malaria vector control'. This version of the Guidelines includes recommendations on two new types of insecticide-treated nets.

Dissemination products

21 Sep 2022

WHO Consolidated guidelines on TB: Module 5: Management of tuberculosis in children and adolescents

These WHO guidelines were published in March 2022, and updated in September 2022.

Dissemination products

27 Jun 2022

WHO Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV

The WHO Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV were published in June 2022, and were informed by three 2018 CIDG reviews

Dissemination products

14 Feb 2022

WHO guideline on control and elimination of human schistosomiasis

Human schistosomiasis is a chronic parasitic disease caused by infection with blood flukes (trematode worms) of the genus Schistosoma. The disease is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America.

Dissemination products

16 Jul 2021

WHO Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

These consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring bring together existing and new clinical and programmatic recommendations across different ages, populations and settings, bringing together all relevant WHO guidance on HIV produced since 2016. It serves as an update to the previous edition of the consolidated guidelines on HIV.

Dissemination products

22 Jun 2021

Covid Guidelines India

LSTM contributes to India specific guidelines for the treatment and management of COVID-19

Dissemination products

27 May 2021

WHO guidelines for plague management

WHO guidelines for plague management: revised recommendations for the use of rapid diagnostic tests, fluoroquinolones for case management and personal protective equipment for prevention of post-mortem transmission

Dissemination products

22 Mar 2021

WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease

A set of 17 new and updated recommendations for the screening of TB disease have been developed

Dissemination products

17 Mar 2021

WHO: Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring

These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living with HIV who are being treated for tuberculosis.

Dissemination products

29 Jan 2021

WHO: The selection and use of essential in vitro diagnostics

Report of the third meeting of the WHO Strategic Advisory Group of Experts on In Vitro Diagnostics, 2020 (including the third WHO model list of essential in vitro diagnostics)

Dissemination products

New ARRIVE Guidelines published

Better reporting of animal research is the aim of the ARRIVE Guidelines

24 Jul 2020

30 Jun 2020

WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection

This document consolidates five guidelines developed by WHO between 2016 and 2020.

Dissemination products

08 Nov 2019

WHO: Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV Policy update (2019)

The Global TB Programme convened a GDG meeting on 14–16 May 2019, in Geneva, Switzerland, to review the evidence for the use of LF-LAM.

Dissemination products

28 Aug 2019

WHO interim guidelines for the treatment of gambiense human African trypanosomiasis

This document focuses on the management of patients affected by gambiense HAT and constitutes an update to the WHO therapeutic guidance issued in 2013.

Dissemination products

READ-IT

Search

Guidelines

Updated: WHO Guidelines for malaria

WHO guideline on policies to protect children from the harmful impact of food marketing

WHO Guidelines for malaria

WHO Consolidated guidelines on TB: Module 5: Management of tuberculosis in children and adolescents

WHO Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV

WHO guideline on control and elimination of human schistosomiasis

WHO Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach

Covid Guidelines India

WHO guidelines for plague management

WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease

WHO: Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring

WHO: The selection and use of essential in vitro diagnostics

New ARRIVE Guidelines published

WHO consolidated guidelines on tuberculosis Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection

WHO: Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV Policy update (2019)

WHO interim guidelines for the treatment of gambiense human African trypanosomiasis

Contact us

Follow us